Lung cancer has the highest mortality of all cancer types worldwide,1 but annual lung cancer screening of high-risk populations with low-dose computed tomography has shown to contribute to a 20% reduction in mortality.2
To meet your needs for low-dose CT for lung cancer screening, Siemens Healthineers offers a wide portfolio of scanners equipped with technologies to provide consistent, reliable image quality and streamline workflow, from acquisition through reading and reporting.
A typical lung cancer screening program involves multiple departments including radiology, oncology, thoracic surgery, and pulmonology.
In oncology, earlier detection means more lung cancers can be found at stages I and II – these are stages where the disease is less complex with higher survivability. Earlier detection of lung cancer carries the obvious benefit of improving outcomes for patients and the less-obvious benefit of decreasing the cost of care because cancer treatment at early stages can be less complex.3,4
Likewise in thoracic surgery these efforts could lead to increased need for biopsies and/or lung resections.
Finally, in pulmonology, heavy smokers are likely to have significant chronic conditions of the lung such as chronic obstructive pulmonary disease (COPD).
The industry’s most comprehensive approach to low dose lung cancer screening
Most SOMATOM computed tomography (CT) and Biograph PET/CT systems are now indicated for low dose lung cancer screening. Siemens offers the industry’s most comprehensive approach to low dose lung cancer screening. This is enabled on most of Siemens’ new CT and PET/CT scanners as well as on the company’s installed base of non-end-of-support scanners, using the standard low-dose lung protocol.*
PET/CT scanning is already a critical tool to help physicians detect and stage lung cancer to determine the appropriate treatment and monitor therapy response. Now Siemens latest PET/CT scanners can be leveraged as a shared service model to support screening efforts to drive operational efficiencies to reduce patient wait times and enable scheduling flexibility— ultimately to improve patient outcomes and support additional downstream revenue streams.
The protocol meets the Centers for Medicare and Medicaid Services (CMS) technical requirements for lung cancer screening, “[the facility must perform] LDCT with volumetric CT dose index (CTDIvol) of ≤3.0 mGy (milliGray) for standard size patients (defined to be 5’ 7” and approximately 155 pounds) with appropriate reductions in CTDIvol for smaller patients and appropriate increases in CTDIvol for larger patients .”5
Reach patients in your community with a self-contained trailer equipped with a SOMATOM go.Up CT scanner.
Discover solutions for cone-beam CT for intraprocedural verification of lesion or tool placement during bronchoscopic interventions.
